Predicting Costs of Care for Patients With Inflammatory Bowel Diseases

Overview

Journal Clin Gastroenterol Hepatol

Specialty Gastroenterology

Date 2016 Dec 8

PMID 27923719

Citations 7

Authors

Benjamin Click

David G Binion

Alyce M Anderson

Affiliations

Soon will be listed here.

Citing Articles

Precision medicine and drug optimization in adult inflammatory bowel disease patients.

Vieujean S, Louis E Therap Adv Gastroenterol. 2023; 16:17562848231173331.

PMID: 37197397 PMC: 10184262. DOI: 10.1177/17562848231173331.

Dose Escalation Patterns of Advanced Therapies in Crohn's Disease and Ulcerative Colitis: A Systematic Literature Review.

Panaccione R, Lee W, Clark R, Kligys K, Campden R, Grieve S Adv Ther. 2023; 40(5):2051-2081.

PMID: 36930430 PMC: 10129944. DOI: 10.1007/s12325-023-02457-6.

Can molecular stratification improve the treatment of inflammatory bowel disease?.

Wang C, Baer H, Gaya D, Nibbs R, Milling S Pharmacol Res. 2019; 148:104442.

PMID: 31491469 PMC: 6902263. DOI: 10.1016/j.phrs.2019.104442.

Increased Healthcare Utilization by Patients With Inflammatory Bowel Disease Covered by Medicaid at a Tertiary Care Center.

Axelrad J, Sharma R, Laszkowska M, Packey C, Rosenberg R, Lebwohl B Inflamm Bowel Dis. 2019; 25(10):1711-1717.

PMID: 30989212 PMC: 7327156. DOI: 10.1093/ibd/izz060.

Diet and exercise: Clinical studies and molecular biology show that diet and other lifestyle changes have significant potential for treating metabolic diseases.

Hunter P EMBO Rep. 2019; 20(4).

PMID: 30862617 PMC: 6446244. DOI: 10.15252/embr.201947966.

References

Sanford D, Thornley P, Teriaky A, Chande N, Gregor J . Opioid use is associated with decreased quality of life in patients with Crohn's disease. Saudi J Gastroenterol. 2014; 20(3):182-7. PMC: 4067915. DOI: 10.4103/1319-3767.133020. View

Nguyen G, Chong C, Chong R . National estimates of the burden of inflammatory bowel disease among racial and ethnic groups in the United States. J Crohns Colitis. 2013; 8(4):288-95. DOI: 10.1016/j.crohns.2013.09.001. View

Limsrivilai J, Stidham R, Govani S, Waljee A, Huang W, Higgins P . Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2016; 15(3):385-392.e2. PMC: 5503504. DOI: 10.1016/j.cgh.2016.09.012. View

Drossman D, Szigethy E . The narcotic bowel syndrome: a recent update. Am J Gastroenterol Suppl. 2014; 2(1):22-30. DOI: 10.1038/ajgsup.2014.6. View

Ananthakrishnan A, Gainer V, Perez R, Cai T, Cheng S, Savova G . Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther. 2013; 37(4):445-54. PMC: 3552092. DOI: 10.1111/apt.12195. View

Targownik L, Nugent Z, Singh H, Bugden S, Bernstein C . The prevalence and predictors of opioid use in inflammatory bowel disease: a population-based analysis. Am J Gastroenterol. 2014; 109(10):1613-20. DOI: 10.1038/ajg.2014.230. View

Vester-Andersen M, Prosberg M, Jess T, Andersson M, Bengtsson B, Blixt T . Disease course and surgery rates in inflammatory bowel disease: a population-based, 7-year follow-up study in the era of immunomodulating therapy. Am J Gastroenterol. 2014; 109(5):705-14. DOI: 10.1038/ajg.2014.45. View

Faust A, Halpern L, Danoff-Burg S, Cross R . Psychosocial factors contributing to inflammatory bowel disease activity and health-related quality of life. Gastroenterol Hepatol (N Y). 2012; 8(3):173-81. PMC: 3365520. View

Jiang J, Click B, Anderson A, Koutroubakis I, Rivers C, Hashash J . Group-Based Trajectory Modeling of Healthcare Financial Charges in Inflammatory Bowel Disease: A Comprehensive Phenotype. Clin Transl Gastroenterol. 2016; 7(7):e181. PMC: 5543483. DOI: 10.1038/ctg.2016.39. View

10.

Silverstein M, Loftus E, Sandborn W, Tremaine W, Feagan B, Nietert P . Clinical course and costs of care for Crohn's disease: Markov model analysis of a population-based cohort. Gastroenterology. 1999; 117(1):49-57. DOI: 10.1016/s0016-5085(99)70549-4. View

11.

Click B, Rivers C, Koutroubakis I, Babichenko D, Anderson A, Hashash J . Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2016; 22(6):1442-9. PMC: 4868776. DOI: 10.1097/MIB.0000000000000763. View

12.

Hirsch A, Yarur A, Dezheng H, Rodriquez D, Krugliak Cleveland N, Ali T . Penetrating Disease, Narcotic Use, and Loop Ostomy Are Associated with Ostomy and IBD-related Complications After Ostomy Surgery in Crohn's Disease Patients. J Gastrointest Surg. 2015; 19(10):1852-61. DOI: 10.1007/s11605-015-2908-y. View

13.

Crocker J, Yu H, Conaway M, Tuskey A, Behm B . Narcotic use and misuse in Crohn's disease. Inflamm Bowel Dis. 2014; 20(12):2234-8. DOI: 10.1097/MIB.0000000000000194. View

14.

Hay J, Hay A . Inflammatory bowel disease: costs-of-illness. J Clin Gastroenterol. 1992; 14(4):309-17. DOI: 10.1097/00004836-199206000-00009. View

15.

Cohen R, Larson L, Roth J, Becker R, Mummert L . The cost of hospitalization in Crohn's disease. Am J Gastroenterol. 2000; 95(2):524-30. DOI: 10.1111/j.1572-0241.2000.01779.x. View

16.

Feagan B, Vreeland M, Larson L, Bala M . Annual cost of care for Crohn's disease: a payor perspective. Am J Gastroenterol. 2000; 95(8):1955-60. DOI: 10.1111/j.1572-0241.2000.02261.x. View

17.

Yu A, Cabanilla L, Wu E, Mulani P, Chao J . The costs of Crohn's disease in the United States and other Western countries: a systematic review. Curr Med Res Opin. 2007; 24(2):319-28. DOI: 10.1185/030079908x260790. View

18.

Gandhi S, Jedel S, Hood M, Mutlu E, Swanson G, Keshavarzian A . The relationship between coping, health competence and patient participation among patients with inactive inflammatory bowel disease. J Crohns Colitis. 2013; 8(5):401-8. DOI: 10.1016/j.crohns.2013.10.005. View

19.

Camilleri M, Katzka D . Enhancing High Value Care in Gastroenterology Practice. Clin Gastroenterol Hepatol. 2016; 14(10):1376-84. PMC: 5028260. DOI: 10.1016/j.cgh.2016.05.022. View

20.

Cohen R, Yu A, Wu E, Xie J, Mulani P, Chao J . Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther. 2010; 31(7):693-707. DOI: 10.1111/j.1365-2036.2010.04234.x. View